Cited by 367Genetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

How ageing processes influence cancer

de Magalhães, João Pedro·2013·Nature Reviews Cancer

Abstract

The ageing of populations worldwide is leading to an unprecedented increase in cancer cases and fatalities. Understanding the links between cancer and ageing is therefore more important than ever. How the interplay of ageing-associated changes affects cancer initiation and progression is complex, however, and some ageing processes probably foster cancer development whereas others hinder it, possibly in a tissue-specific manner. In the emerging age of cancer, how can our growing understanding of the biology of ageing inform cancer biology?

Integrity signals

Registry

Crossref · 10.1038/nrc3497

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The evolution of large body sizes and longevity is strongly associated with the evolution of short telomeres and telomerase suppression, presumably for tumour suppression.

    “Taken together, it seems that the evolution of large body sizes and longevity is strongly associated with the evolution of short telomeres and telomerase suppression, presumably for tumour suppression (de Magalhaes, 2013; Gomes et al., 2011).”

    From Stress, cell senescence and organismal ageing (2018) · cites this paper as de Magalhaes, 2013

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
de Magalhães, J. P.
Venue
Nature Reviews Cancer
Published
2013-04-24
Volume
13
Issue
5
Pages
357-365
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W2151807108
Cited by
367
References
27
Citations by year
2026: 12 · 2025: 29 · 2024: 37 · 2023: 36 · 2022: 35 · 2021: 35 · 2020: 34 · 2019: 23 · 2018: 36 · 2017: 21 · 2016: 26 · 2015: 21 · 2014: 19 · 2013: 2
FWCI
1.40
Type
journal article
Language
en
Open access
closed
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • European Science Foundation
  • Biotechnology and Biological Sciences Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
aging, cancer, carcinogenesis, premature aging, longevity, tumor initiation, tumor progression
MeSH terms
Aging, Animals, DNA Damage, Homeostasis, Humans, Neoplasms, Risk Factors, Caloric Restriction, Telomere Homeostasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review